CAPTRUST Financial Advisors’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CNTX
CAPTRUST Financial Advisors's CNTX Position: Q3 2026 in Review
CAPTRUST Financial Advisors opened a new position in Context Therapeutics (CNTX) in Q3 2026: 13,098 shares worth $3.94K. The stake represents ﹤0.01% of the portfolio and ranks #3376 among its holdings.
87 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.
- CAPTRUST Financial Advisors held 13,098 shares of Context Therapeutics worth $3.94K as of Q3 2026.
- Context Therapeutics was a new CAPTRUST Financial Advisors position in Q3 2026.
- Context Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3376 holding.
- 87 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.